Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment:

Hans van Suijdam (1950) at present Director Strategic Projects in China, will be appointed Director Corporate Operational Audit (COA) and Compliance Officer as per 1 April 2009.

His current assignment in China, including the activities related to the strategic partnership of DSM with North China Pharmaceutical Group Corporation, will be taken over and continued by Weiming Jiang, President DSM China and the involved Business Groups.

In his new role as Director Corporate Operational Audit and Compliance Officer Hans van Suijdam succeeds Roelof Mulder, who unexpectedly passed away in November last year.

Hans van Suijdam will report to F. Sijbesma, Chairman of the DSM Managing Board.